Surgical Site Infection Control Market Research Report - Global Forecast till 2027

Global Surgical Site Infection Control Market Report: Information by Product (Disinfectants, Surgical Scrubs), Procedure (Cataract Surgery, Caesarean Section), Type of Infection (Superficial Incisional SSI, Deep Incisional SSI)—Global Forecast till 2027

ID: MRFR/HC/6359-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The Global Surgical Site Infection Control Market is expected to register a CAGR of 6.7% during the forecast period of 2018 to 2023.


A surgical site infection occurs after surgery in any part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Other surgical site infections are more serious and can involve tissues under the skin, organs, or implanted material.


Factors such as increasing cost of healthcare and mounting prevalence of certain fatal diseases including cancer, coronary heart diseases, etc., also increasing geriatric population are driving the growth of the surgical site infection control market. Other factors such as the rising number of surgeries, increase in hospital-acquired infection, and rapidly increasing geriatric population are fueling the market growth. However, the rise in use of outpatient treatment and lack of awareness of hospital infection prevention and control are hampering the market growth.


Segmentation


The global surgical site infection control market is segmented based on product, procedure, type of infection, end user, and region.


On the basis of product, the market is segmented into Manual Reprocessors Solution, Disinfectants, Surgical Scrubs, Surgical Drapes, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, and Others. The Disinfectants is segmented into hand disinfectants and skin disinfectants.


On the basis of procedure, the market is segmented into cataract surgery, cesarean section, dental restoration, gastric bypass, and others.


On the type of infection, the market is segmented into Superficial Incisional SSI, Deep Incisional SSI


Organ or Space SSI.


On the basis of End User, the market is segmented into hospitals and ambulatory surgical centers.


Regional Market Summary


 Global Surgical Site Infection Control Market Share (%), by Region, 2017
Global Surgical Site Infection Control Market Share by Region, 2017


The Americas dominated the global market of surgical site infection control. Increasing healthcare expenditure, rising incidence of chronic diseases, increasing awareness regarding healthcare management, and growing geriatric population are some other factors expected to drive the growth of the Americas surgical site infection control market.


In 2017, it was estimated that Europe stood second in the global healthcare information systems market. This can be attributed due to the increasing awareness regarding hygiene and sanitation, government support for ensuring high degree infection prevention, formulation of various awareness programs by NGO and Government, development of technologically advanced medical products, and growing number of surgical site infection cases are some other factors expected to drive growth of the target market over the forecasted period. However, strict regulation is the factors expected to hamper the growth of the global surgical site infection control market over the forecast period.


Asia-Pacific was the fastest growing region for the global surgical site infection control market in 2017. Asia-Pacific has a huge market potential for the Healthcare IT industry. India and China are some of the rapidly growing countries, followed by South Korea. Consequently, the government in these rapidly developing economies have taken various efforts to improve healthcare services and provide better infrastructure.


On the other hand, the Middle East and Africa held the least share in the global surgical site infection control market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies such as the UAE, Kuwait, Dubai, and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the global surgical site infection control market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


 Intended Audience



  • Pharmaceutical companies

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Market research and consulting service providers


 Market Segmentation and Key Market Players


Global Surgical Site Infection Control Market, by Product



  • Manual Reprocessors Solution



  • Disinfectants

    • Hand Disinfectants

    • Skin Disinfectants





  • Surgical Scrubs

  • Surgical Drapes

  • Skin Preparation Solution

  • Medical Nonwovens

  • Surgical Gloves

  • Others


Global Surgical Site Infection Control Market, by Procedure



  • Cataract Surgery

  • Cesarean Section

  • Dental Restoration

  • Gastric Bypass

  • Others


Global Surgical Site Infection Control Market, by Type of Infection



  • Superficial Incisional SSI

  • Deep Incisional SSI

  • Organ or Space SSI


Global Surgical Site Infection Control Market, by End User



  • Hospitals

  • Ambulatory Surgical Centers


Global Surgical Site Infection Control Market, by Key Players



  • 3M

  • Becton Dickinson and Company

  • Belimed AG

  • bioMerieux SA

  • Getinge Group

  • Johnson & Johnson

  • Kimberly-Clark Corporation

  • Sotera Health

  • Ansell Limited

  • Steris Corporation

  • Lac-Mac Limited

  • Pacon Manufacturing Corp

  • American Polyfilm Inc.

  • Others



Frequently Asked Questions (FAQ) :


Surgical site infection control market is projected to grow at a 6.7% CAGR between 2018-2023.

The Americas is expected to dominate the surgical site infection control market.

Rising prevalence of fatal diseases and increasing number of surgeries are the key factors driving the surgical site infection control market.

Lack of awareness and high cost may limit the surgical site infection control market.

Different end users of surgical site infection control market include ambulatory surgical centers, hospitals, and others.

Table of Contents:

Chapter 1.Report Prologue

Chapter 2.Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3.Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Surgical Site Infection Control Market, by Product

6.1 Introduction

6.2 Manual Reprocessors Solution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3 Disinfectants

6.3.1 Hand Disinfectants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2 Skin Disinfectants

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4 Surgical Scrubs

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5 Surgical Drapes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6 Skin Preparation Solution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.7 Medical Nonwovens

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.8 Surgical Gloves

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.9 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 7. Global Surgical Site Infection Control Market, by Procedure

7.1 Introduction

7.2 Cataract Surgery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3 Cesarean Section

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4 Dental Restoration

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5 Gastric Bypass

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 8. Global Surgical Site Infection Control Market, by Product of Infection

8.1 Introduction

8.2 Superficial Incisional SSI

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3 Deep Incisional SSI

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Organ or Space SSI

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 9. Global Surgical Site Infection Control Market, by End User

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4 Academic and Research Institution

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.5 Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

Chapter 10. Global Surgical Site Infection Control Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 3M

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Becton, Dickinson and Company

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Belimed AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 bioMerieux SA

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Getinge Group

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Johnson & Johnson

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Kimberly-Clark Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Sotera Health

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Ansell Limited

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Steris Corporation

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Lac-Mac Limited

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Pacon Manufacturing Corp.

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 American Polyfilm Inc.

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Surgical Site Infection Control Market Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Surgical Site Infection Control Market Synopsis, 2020–2027

Table 2 Global Surgical Site Infection Control Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3 Global Surgical Site Infection Control Market, by Region, 2020–2027 (USD Million)

Table 4 Global Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 5 Global Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 6 Global Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 7 Global Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 8 North America: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 9 North America: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 10 North America: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 11 North America: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 12 US: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 13 US: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 14 US: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 15 US: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 16 Canada: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 17 Canada: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 18 Canada: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 19 Canada: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 20 South America: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 21 South America: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 22 South America: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 23 South America: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 24 Europe: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 25 Europe: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 26 Europe: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 27 Europe: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 28 Western Europe: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 29 Western Europe: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 30 Western Europe: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 31 Western Europe: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 32 Eastern Europe: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 33 Eastern Europe: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 34 Eastern Europe: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 35 Eastern Europe: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 36 Asia-Pacific: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 37 Asia-Pacific: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 38 Asia-Pacific: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 39 Asia-Pacific: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

Table 40 Middle East & Africa: Surgical Site Infection Control Market, by Product, 2020–2027 (USD Million)

Table 41 Middle East & Africa: Surgical Site Infection Control Market, by Procedure, 2020–2027 (USD Million)

Table 42 Middle East & Africa: Surgical Site Infection Control Market, by Type of Infection, 2020–2027 (USD Million)

Table 43 Middle East & Africa: Surgical Site Infection Control Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Surgical Site Infection Control Market

Figure 3 Segmentation Market Dynamics for Global Surgical Site Infection Control Market

Figure 4 Global Surgical Site Infection Control Market Share, by Product, 2020

Figure 5 Global Surgical Site Infection Control Market Share, by Procedure, 2020

Figure 6 Global Surgical Site Infection Control Market Share, by Type of Infection, 2020

Figure 7 Global Surgical Site Infection Control Market Share, by End User, 2020

Figure 8 Global Surgical Site Infection Control Market Share, by Region, 2020

Figure 9 North America: Global Surgical Site Infection Control Market Share, by Country, 2020

Figure 10 Europe: Global Surgical Site Infection Control Market Share, by Country, 2020

Figure 11 Asia-Pacific: Global Surgical Site Infection Control Market Share, by Country, 2020

Figure 12 Middle East & Africa: Global Surgical Site Infection Control Market Share, by Region, 2020

Figure 13 Global Surgical Site Infection Control Market: Company Share Analysis, 2020 (%)

Figure 14 3M: Key Financials

Figure 15 3M: Segmental Revenue

Figure 16 3M: Geographical Revenue

Figure 17 Becton, Dickinson and Company: Key Financials

Figure 18 Becton, Dickinson and Company: Segmental Revenue

Figure 19 Becton, Dickinson and Company: Geographical Revenue

Figure 20 Belimed AG: Key Financials

Figure 21 Belimed AG: Segmental Revenue

Figure 22 Belimed AG: Geographical Revenue

Figure 23 bioMerieux SA: Key Financials

Figure 24 bioMerieux SA: Segmental Revenue

Figure 25 bioMerieux SA: Geographical Revenue

Figure 26 Getinge Group: Key Financials

Figure 27 Getinge Group: Segmental Revenue

Figure 28 Getinge Group: Geographical Revenue

Figure 29 Johnson & Johnson: Key Financials

Figure 30 Johnson & Johnson: Segmental Revenue

Figure 31 Johnson & Johnson: Geographical Revenue

Figure 32 Kimberly-Clark Corporation: Key Financials

Figure 33 Kimberly-Clark Corporation: Segmental Revenue

Figure 34 Kimberly-Clark Corporation: Geographical Revenue

Figure 35 Sotera Health: Key Financials

Figure 36 Sotera Health: Segmental Revenue

Figure 37 Sotera Health: Geographical Revenue

Figure 38 Ansell Limited: Key Financials

Figure 39 Ansell Limited: Segmental Revenue

Figure 40 Ansell Limited: Geographical Revenue

Figure 41 Steris Corporation: Key Financials

Figure 42 Steris Corporation: Segmental Revenue

Figure 43 Steris Corporation: Geographical Revenue

Figure 44 Lac-Mac Limited: Key Financials

Figure 45 Lac-Mac Limited: Segmental Revenue

Figure 46 Lac-Mac Limited: Geographical Revenue

Figure 47 Lac-Mac Limited: Key Financials

Figure 48 Pacon Manufacturing Corp.: Segmental Revenue

Figure 49 Pacon Manufacturing Corp.: Geographical Revenue

Figure 50 Pacon Manufacturing Corp.: Key Financials

Figure 51 American Polyfilm Inc.: Segmental Revenue

Figure 52 American Polyfilm Inc.: Geographical Revenue

Figure 53 American Polyfilm Inc.: Key Financials



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.